Back to funds

B Group, Inc.

Updated 6 days ago

Managed by B Group, Inc. • Latest filing Q3 2026

Portfolio value
$162.1M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$135.4M
Q1 2026$134.9M
Q2 2026$213M
Q3 2026$162.1M

Top holdings

19 positions as of Q3 2026

View filing
A

ADMA BIOLOGICS INC

Value
$32.7M
Shares
3.26M
% Port
20.18%
F

FAETH THERAPEUTICS INC

Value
$18.1M
Shares
610.2K
% Port
11.19%
?
3.N/A

PALISADE BIO INC

Value
$15.4M
Shares
11.41M
% Port
9.50%
?
4.N/A

NRX PHARMACEUTICALS INC

Value
$12.5M
Shares
4.28M
% Port
7.70%
Z

ZAI LAB LTD

Value
$11.9M
Shares
450.6K
% Port
7.32%
P

PRAXIS PRECISION MEDICINES I

Value
$9.7M
Shares
33.2K
% Port
5.97%
B

SIGHT SCIENCES INC

Value
$9.1M
Shares
970.0K
% Port
5.60%
T

TAYSHA GENE THERAPIES INC

Value
$8.8M
Shares
1.80M
% Port
5.41%
J

IOVANCE BIOTHERAPEUTICS INC

Value
$6.3M
Shares
425.0K
% Port
3.88%
G

STRUCTURE THERAPEUTICS INC

Value
$5.6M
Shares
180.0K
% Port
3.47%
S

SPYRE THERAPEUTICS INC

Value
$5.6M
Shares
62.5K
% Port
3.43%
C

CELLECTIS S A

Value
$5M
Shares
3.28M
% Port
3.06%
A

AURA BIOSCIENCES INC

Value
$4.8M
Shares
764.2K
% Port
2.96%
D

BRIGHT MINDS BIOSCIENCES INC

Value
$4.7M
Shares
95.0K
% Port
2.92%
O

ORUKA THERAPEUTICS INC

Value
$4.6M
Shares
55.0K
% Port
2.83%
A

ASSEMBLY BIOSCIENCES INC

Value
$4.1M
Shares
175.7K
% Port
2.55%
R

ULTRAGENYX PHARMACEUTICAL IN

Value
$2M
Shares
135.0K
% Port
1.25%
F

FOGHORN THERAPEUTICS INC

Value
$714K
Shares
200.0K
% Port
0.44%
Q

Q32 BIO INC

Value
$538K
Shares
65.0K
% Port
0.33%

Explore